SCHEMBL2614903

SCHEMBL2614903

CC(=O)Nc1cc2nc3ccccc3oc-2cc1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.58
RAB9A P51151 8/20 0.58
ALDH1A1 P00352 7/20 0.58
MEN1 O00255 7/20 0.58
KMT2A Q03164 7/20 0.58
MAPT P10636 6/20 0.58
POLB P06746 3/20 0.58
ALPL P05186 1/20 0.58
ALPI P09923 1/20 0.58
ALPG P10696 1/20 0.58
RECQL P46063 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
NPC1 O15118 6/20 0.51
SMN1; SMN2 Q16637 5/20 0.49
HPGD P15428 4/20 0.49
LMNA P02545 2/20 0.49
MAOA P21397 2/20 0.49
CYP1A2 P05177 1/20 0.49
HSD17B10 Q99714 1/20 0.49
NFKB1 P19838 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3777988 0.85 RAB9A (0.55) KDM4ERAB9AALDH1A1MEN1KMT2A
SCHEMBL3771904 0.85 APP (0.55) KDM4ERAB9AALDH1A1MEN1KMT2A
SCHEMBL3774405 0.82 APP (0.58) KDM4ERAB9AALDH1A1MEN1KMT2A
Exfoliazone SCHEMBL30080694 0.82 RAB9A (0.47) KDM4ERAB9AALDH1A1MEN1KMT2A
SCHEMBL2609271 0.76 MAPT (0.68) KDM4ERAB9AALDH1A1MEN1KMT2A
SCHEMBL2609270 0.76 MAPT (0.68) KDM4ERAB9AALDH1A1MEN1KMT2A
SCHEMBL28735080 0.76 KDM4E (0.62) KDM4ERAB9AALDH1A1MEN1KMT2A
SCHEMBL9326807 0.76 MEN1 (0.63) KDM4ERAB9AALDH1A1MEN1KMT2A
SCHEMBL1635805 0.75 RAB9A (0.49) KDM4ERAB9AALDH1A1MEN1KMT2A
SCHEMBL2609261 0.74 MAPT (1.00) KDM4ERAB9AALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009003625-A1 AMINOPHENOXAZINONE AS AN ANTI-TUMOUR AND ANTI-INFLAMMATORY AGENT EBERHARD-KARLS-UNIVERSITAET TUEBINGEN UNIVERSITAETSKILINIKUM (DE) 2009-01-08 WO claimed
US-8559093-B2 Electrochromic mirror reflective element for vehicular rearview mirror assembly DONNELLY CORPORATION (US) 2013-10-15 US disclosed
US-20130063802-A1 VARIABLE TRANSMISSION WINDOW DONNELLY CORPORATION (US) 2013-03-14 US disclosed
US-8294975-B2 Automotive rearview mirror assembly DONNELLY CORPORATION (US) 2012-10-23 US disclosed
US-20120206790-A1 ELECTROCHROMIC MIRROR REFLECTIVE ELEMENT FOR VEHICULAR REARVIEW MIRROR ASSEMBLY DONNELLY CORPORATION (US) 2012-08-16 US disclosed
US-8164817-B2 Method of forming a mirrored bent cut glass shape for vehicular exterior rearview mirror assembly DONNELLY CORPORATION (US) 2012-04-24 US disclosed
US-20110045172-A1 METHOD OF FORMING A MIRRORED BENT CUT GLASS SHAPE FOR VEHICULAR EXTERIOR REARVIEW MIRROR ASSEMBLY DONNELLY CORPORATION (US) 2011-02-24 US disclosed
US-20100324285-A1 ANTIINFLAMMATORY AGENT COMPRISING 2-AMINOPHENOL OR DERIVATIVE THEREOF AS ACTIVE INGREDIENT KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2010-12-23 US disclosed
US-7821697-B2 Exterior reflective mirror element for a vehicular rearview mirror assembly DONNELLY CORPORATION (US) 2010-10-26 US disclosed
US-7821697-B2 Exterior reflective mirror element for a vehicular rearview mirror assembly DONNELLY CORPORATION (US) 2010-10-26 US disclosed
US-20080291522-A1 EXTERIOR REFLECTIVE MIRROR ELEMENT FOR A VEHICLE REARVIEW MIRROR ASSEMBLY DONNELLY CORPORATION (US) 2008-11-27 US disclosed
US-20080291522-A1 EXTERIOR REFLECTIVE MIRROR ELEMENT FOR A VEHICLE REARVIEW MIRROR ASSEMBLY DONNELLY CORPORATION (US) 2008-11-27 US disclosed
US-20080094685-A1 VEHICULAR EXTERIOR MIRROR DONNELLY CORPORATION (US) 2008-04-24 US disclosed
US-20080094685-A1 VEHICULAR EXTERIOR MIRROR DONNELLY CORPORATION (US) 2008-04-24 US disclosed
US-7349144-B2 Exterior electrochromic reflective mirror element for a vehicular rearview mirror assembly DONNELLY CORPORATION (US) 2008-03-25 US disclosed
US-7349144-B2 Exterior electrochromic reflective mirror element for a vehicular rearview mirror assembly DONNELLY CORPORATION (US) 2008-03-25 US disclosed
US-20070184284-A1 Exterior electrochromic reflective mirror element for a vehicular rearview mirror assembly DONNELLY CORPORATION (US) 2007-08-09 US disclosed
US-20070184284-A1 Exterior electrochromic reflective mirror element for a vehicular rearview mirror assembly DONNELLY CORPORATION (US) 2007-08-09 US disclosed
US-7202987-B2 Electrochromic polymeric solid films, manufacturing electrochromic devices using such solid films, and processes for making such solid films and devices DONNELLY CORPORATION (US) 2007-04-10 US disclosed
US-7202987-B2 Electrochromic polymeric solid films, manufacturing electrochromic devices using such solid films, and processes for making such solid films and devices DONNELLY CORPORATION (US) 2007-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324285-A1 ANTIINFLAMMATORY AGENT COMPRISING 2-AMINOPHENOL OR DERIVATIVE THEREOF AS ACTIVE INGREDIENT PTGES2, PTGS2, PTGES KDM4E 1347/4885RAB9A 4632/4885ALDH1A1 535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.